nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—Sensation of warmth—Hydrochlorothiazide—nephrolithiasis	0.0356	0.089	CcSEcCtD
Ondansetron—Atrioventricular block second degree—Hydrochlorothiazide—nephrolithiasis	0.0335	0.0839	CcSEcCtD
Ondansetron—Feeling cold—Hydrochlorothiazide—nephrolithiasis	0.0335	0.0839	CcSEcCtD
Ondansetron—Raised liver function tests—Hydrochlorothiazide—nephrolithiasis	0.0207	0.0519	CcSEcCtD
Ondansetron—SLC47A2—renal system—nephrolithiasis	0.0174	0.0914	CbGeAlD
Ondansetron—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0428	CcSEcCtD
Ondansetron—SLC47A2—kidney—nephrolithiasis	0.0168	0.0884	CbGeAlD
Ondansetron—SLC47A2—cortex of kidney—nephrolithiasis	0.0164	0.0861	CbGeAlD
Ondansetron—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.016	0.0389	CbGpPWpGaD
Ondansetron—HTR4—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0151	0.0368	CbGpPWpGaD
Ondansetron—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.0148	0.0362	CbGpPWpGaD
Ondansetron—CYP1A2—urine—nephrolithiasis	0.0131	0.0687	CbGeAlD
Ondansetron—HTR4—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0127	0.031	CbGpPWpGaD
Ondansetron—CYP2C9—urine—nephrolithiasis	0.0124	0.0652	CbGeAlD
Ondansetron—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0305	CcSEcCtD
Ondansetron—CYP2E1—urine—nephrolithiasis	0.0117	0.0618	CbGeAlD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0105	0.0255	CbGpPWpGaD
Ondansetron—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0103	0.0251	CbGpPWpGaD
Ondansetron—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.0097	0.0243	CcSEcCtD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00957	0.0233	CbGpPWpGaD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00957	0.0233	CbGpPWpGaD
Ondansetron—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00956	0.0233	CbGpPWpGaD
Ondansetron—CYP3A4—urine—nephrolithiasis	0.00945	0.0497	CbGeAlD
Ondansetron—CYP2D6—urine—nephrolithiasis	0.0093	0.0489	CbGeAlD
Ondansetron—HTR3A—Ion channel transport—CLCN4—nephrolithiasis	0.00837	0.0204	CbGpPWpGaD
Ondansetron—HTR3A—Ion channel transport—CLCN5—nephrolithiasis	0.00837	0.0204	CbGpPWpGaD
Ondansetron—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00819	0.0431	CbGeAlD
Ondansetron—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00803	0.0201	CcSEcCtD
Ondansetron—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00788	0.0197	CcSEcCtD
Ondansetron—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00734	0.0184	CcSEcCtD
Ondansetron—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00734	0.0184	CcSEcCtD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00725	0.0177	CbGpPWpGaD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00725	0.0177	CbGpPWpGaD
Ondansetron—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00701	0.0369	CbGeAlD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00674	0.0164	CbGpPWpGaD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00674	0.0164	CbGpPWpGaD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00674	0.0164	CbGpPWpGaD
Ondansetron—SLC47A1—nephron tubule—nephrolithiasis	0.00669	0.0352	CbGeAlD
Ondansetron—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00642	0.0161	CcSEcCtD
Ondansetron—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.00633	0.0158	CcSEcCtD
Ondansetron—HTR1B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00631	0.0154	CbGpPWpGaD
Ondansetron—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00626	0.0157	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00626	0.0157	CcSEcCtD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00617	0.015	CbGpPWpGaD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00617	0.015	CbGpPWpGaD
Ondansetron—SLC47A1—renal system—nephrolithiasis	0.00608	0.032	CbGeAlD
Ondansetron—SLC47A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00601	0.0146	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00596	0.0145	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00596	0.0145	CbGpPWpGaD
Ondansetron—SLC47A1—kidney—nephrolithiasis	0.00588	0.0309	CbGeAlD
Ondansetron—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00585	0.0147	CcSEcCtD
Ondansetron—SLC47A1—cortex of kidney—nephrolithiasis	0.00573	0.0301	CbGeAlD
Ondansetron—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00562	0.0141	CcSEcCtD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00532	0.013	CbGpPWpGaD
Ondansetron—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00531	0.0133	CcSEcCtD
Ondansetron—HTR1B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00531	0.0129	CbGpPWpGaD
Ondansetron—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00528	0.0132	CcSEcCtD
Ondansetron—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00525	0.0131	CcSEcCtD
Ondansetron—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00521	0.013	CcSEcCtD
Ondansetron—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0049	0.0123	CcSEcCtD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00486	0.0118	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00486	0.0118	CbGpPWpGaD
Ondansetron—HTR1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00481	0.0117	CbGpPWpGaD
Ondansetron—HTR4—G alpha (s) signalling events—PTH—nephrolithiasis	0.00479	0.0117	CbGpPWpGaD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00467	0.0114	CbGpPWpGaD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00467	0.0114	CbGpPWpGaD
Ondansetron—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00464	0.0116	CcSEcCtD
Ondansetron—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00455	0.0114	CcSEcCtD
Ondansetron—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00446	0.0112	CcSEcCtD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00434	0.0106	CbGpPWpGaD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00434	0.0106	CbGpPWpGaD
Ondansetron—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0043	0.0108	CcSEcCtD
Ondansetron—HTR1A—renal system—nephrolithiasis	0.00419	0.0221	CbGeAlD
Ondansetron—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00419	0.0105	CcSEcCtD
Ondansetron—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00413	0.0103	CcSEcCtD
Ondansetron—HTR1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00404	0.00985	CbGpPWpGaD
Ondansetron—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00395	0.00988	CcSEcCtD
Ondansetron—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00392	0.00982	CcSEcCtD
Ondansetron—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00972	CcSEcCtD
Ondansetron—SLC47A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00387	0.00944	CbGpPWpGaD
Ondansetron—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00963	CcSEcCtD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00384	0.00937	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00384	0.00937	CbGpPWpGaD
Ondansetron—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00383	0.00958	CcSEcCtD
Ondansetron—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00945	CcSEcCtD
Ondansetron—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00376	0.0094	CcSEcCtD
Ondansetron—KCNH2—renal system—nephrolithiasis	0.00373	0.0196	CbGeAlD
Ondansetron—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0037	0.00926	CcSEcCtD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00368	0.00898	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00368	0.00898	CbGpPWpGaD
Ondansetron—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00368	0.00921	CcSEcCtD
Ondansetron—Cough—Hydrochlorothiazide—nephrolithiasis	0.00365	0.00914	CcSEcCtD
Ondansetron—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00357	0.00892	CcSEcCtD
Ondansetron—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00889	CcSEcCtD
Ondansetron—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00352	0.00881	CcSEcCtD
Ondansetron—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00349	0.00873	CcSEcCtD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00343	0.00835	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00343	0.00835	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00343	0.00835	CbGpPWpGaD
Ondansetron—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00342	0.00855	CcSEcCtD
Ondansetron—CYP3A5—nephron tubule—nephrolithiasis	0.00339	0.0178	CbGeAlD
Ondansetron—Shock—Hydrochlorothiazide—nephrolithiasis	0.00336	0.00841	CcSEcCtD
Ondansetron—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00334	0.00835	CcSEcCtD
Ondansetron—CYP1A2—renal system—nephrolithiasis	0.00319	0.0168	CbGeAlD
Ondansetron—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00319	0.00799	CcSEcCtD
Ondansetron—CYP2E1—nephron tubule—nephrolithiasis	0.00316	0.0166	CbGeAlD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00313	0.00764	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00313	0.00764	CbGpPWpGaD
Ondansetron—CYP3A5—renal system—nephrolithiasis	0.00308	0.0162	CbGeAlD
Ondansetron—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00307	0.00768	CcSEcCtD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00305	0.00744	CbGpPWpGaD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00305	0.00744	CbGpPWpGaD
Ondansetron—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00763	CcSEcCtD
Ondansetron—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00304	0.0076	CcSEcCtD
Ondansetron—CYP3A5—kidney—nephrolithiasis	0.00298	0.0157	CbGeAlD
Ondansetron—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00295	0.00737	CcSEcCtD
Ondansetron—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00731	CcSEcCtD
Ondansetron—Pain—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00731	CcSEcCtD
Ondansetron—HTR4—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00292	0.00711	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00291	0.0071	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00291	0.0071	CbGpPWpGaD
Ondansetron—CYP3A5—cortex of kidney—nephrolithiasis	0.0029	0.0153	CbGeAlD
Ondansetron—CYP2E1—renal system—nephrolithiasis	0.00287	0.0151	CbGeAlD
Ondansetron—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00282	0.00705	CcSEcCtD
Ondansetron—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00279	0.00699	CcSEcCtD
Ondansetron—CYP2E1—kidney—nephrolithiasis	0.00278	0.0146	CbGeAlD
Ondansetron—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00272	0.00679	CcSEcCtD
Ondansetron—CYP2E1—cortex of kidney—nephrolithiasis	0.00271	0.0142	CbGeAlD
Ondansetron—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00676	CcSEcCtD
Ondansetron—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00676	CcSEcCtD
Ondansetron—HTR1B—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00269	0.00655	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.0026	0.00633	CbGpPWpGaD
Ondansetron—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00252	0.0063	CcSEcCtD
Ondansetron—HTR4—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0025	0.00609	CbGpPWpGaD
Ondansetron—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00614	CcSEcCtD
Ondansetron—SLC47A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00244	0.00595	CbGpPWpGaD
Ondansetron—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00242	0.00605	CcSEcCtD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00237	0.00579	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00237	0.00579	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00237	0.00579	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00237	0.00579	CbGpPWpGaD
Ondansetron—OPRM1—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00237	0.00578	CbGpPWpGaD
Ondansetron—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00585	CcSEcCtD
Ondansetron—CYP3A4—renal system—nephrolithiasis	0.00231	0.0122	CbGeAlD
Ondansetron—CYP2D6—renal system—nephrolithiasis	0.00228	0.012	CbGeAlD
Ondansetron—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00226	0.00566	CcSEcCtD
Ondansetron—CYP3A4—kidney—nephrolithiasis	0.00224	0.0118	CbGeAlD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00221	0.00538	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00221	0.00538	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—RGS14—nephrolithiasis	0.0022	0.00537	CbGpPWpGaD
Ondansetron—CYP2D6—kidney—nephrolithiasis	0.0022	0.0116	CbGeAlD
Ondansetron—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00544	CcSEcCtD
Ondansetron—Rash—Hydrochlorothiazide—nephrolithiasis	0.00215	0.00539	CcSEcCtD
Ondansetron—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00215	0.00539	CcSEcCtD
Ondansetron—Headache—Hydrochlorothiazide—nephrolithiasis	0.00214	0.00536	CcSEcCtD
Ondansetron—HTR1A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00205	0.00499	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—RGS14—nephrolithiasis	0.002	0.00487	CbGpPWpGaD
Ondansetron—CYP3A7—Biological oxidations—SLC26A1—nephrolithiasis	0.00199	0.00484	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00197	0.00479	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00197	0.00479	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—CHRM3—nephrolithiasis	0.0019	0.00464	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.0018	0.00439	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.0018	0.00439	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—PTH—nephrolithiasis	0.00174	0.00424	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00167	0.00408	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00167	0.00408	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00157	0.00383	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00149	0.00363	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00149	0.00363	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—DGKH—nephrolithiasis	0.00149	0.00362	CbGpPWpGaD
Ondansetron—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00148	0.0036	CbGpPWpGaD
Ondansetron—CYP2E1—Biological oxidations—SLC26A1—nephrolithiasis	0.00144	0.0035	CbGpPWpGaD
Ondansetron—CYP3A5—Biological oxidations—SLC26A1—nephrolithiasis	0.00143	0.0035	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—ADCY10—nephrolithiasis	0.00139	0.00339	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—DGKH—nephrolithiasis	0.00135	0.00329	CbGpPWpGaD
Ondansetron—HTR1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00122	0.00297	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00119	0.0029	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—RGS14—nephrolithiasis	0.00118	0.00288	CbGpPWpGaD
Ondansetron—OPRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00108	0.00262	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00108	0.00262	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00104	0.00254	CbGpPWpGaD
Ondansetron—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00102	0.00249	CbGpPWpGaD
Ondansetron—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00101	0.00247	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—PTH—nephrolithiasis	0.000983	0.0024	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—CHRM3—nephrolithiasis	0.000976	0.00238	CbGpPWpGaD
Ondansetron—HTR1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000928	0.00226	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000921	0.00225	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00092	0.00224	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—PTH—nephrolithiasis	0.000893	0.00218	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.000864	0.00211	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—RGS14—nephrolithiasis	0.000835	0.00204	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000812	0.00198	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—DGKH—nephrolithiasis	0.000798	0.00194	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000798	0.00194	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000795	0.00194	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000795	0.00194	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.000737	0.0018	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—PTH—nephrolithiasis	0.000727	0.00177	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000702	0.00171	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000701	0.00171	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000667	0.00163	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000642	0.00156	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—RGS14—nephrolithiasis	0.000636	0.00155	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000621	0.00151	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000606	0.00148	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ADCY10—nephrolithiasis	0.00058	0.00141	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CHRM3—nephrolithiasis	0.000577	0.00141	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—DGKH—nephrolithiasis	0.000564	0.00138	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—PTH—nephrolithiasis	0.000554	0.00135	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000548	0.00134	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—PTH—nephrolithiasis	0.000528	0.00129	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.000512	0.00125	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.000498	0.00121	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—RGS14—nephrolithiasis	0.000493	0.0012	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.000473	0.00115	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000449	0.00109	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GRHPR—nephrolithiasis	0.000448	0.00109	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000442	0.00108	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RGS14—nephrolithiasis	0.000435	0.00106	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.00043	0.00105	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000411	0.001	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.000408	0.000994	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—AGXT—nephrolithiasis	0.000399	0.000973	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000396	0.000966	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	0.000376	0.000916	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—PTH—nephrolithiasis	0.000373	0.000909	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—PTH—nephrolithiasis	0.000363	0.000884	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00036	0.000877	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000342	0.000834	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—APRT—nephrolithiasis	0.000339	0.000827	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	0.000339	0.000827	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—DGKH—nephrolithiasis	0.000333	0.000812	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000333	0.000812	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—PTH—nephrolithiasis	0.000329	0.000802	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GRHPR—nephrolithiasis	0.000324	0.000791	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GRHPR—nephrolithiasis	0.000324	0.000789	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000313	0.000763	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000311	0.000757	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—DGKH—nephrolithiasis	0.000294	0.000717	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000294	0.000717	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AGXT—nephrolithiasis	0.000289	0.000705	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AGXT—nephrolithiasis	0.000289	0.000703	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	0.000284	0.000693	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—SPP1—nephrolithiasis	0.000265	0.000645	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	0.000254	0.000619	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000254	0.000619	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—APRT—nephrolithiasis	0.000246	0.000599	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	0.000246	0.000599	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—SLC26A1—nephrolithiasis	0.000245	0.000598	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—APRT—nephrolithiasis	0.000245	0.000598	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—AQP1—nephrolithiasis	0.000242	0.000589	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000241	0.000587	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.00023	0.000561	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.000228	0.000556	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PTH—nephrolithiasis	0.00022	0.000537	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—CHRM3—nephrolithiasis	0.000219	0.000533	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CHRM3—nephrolithiasis	0.000213	0.000518	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000205	0.0005	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000203	0.000496	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000195	0.000475	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTH—nephrolithiasis	0.000195	0.000474	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000184	0.000447	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—AQP1—nephrolithiasis	0.000175	0.000427	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—AQP1—nephrolithiasis	0.000175	0.000426	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000174	0.000425	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000174	0.000425	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000174	0.000424	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000173	0.000422	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000173	0.000422	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTH—nephrolithiasis	0.000168	0.000409	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CHRM3—nephrolithiasis	0.000158	0.000386	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CHRM3—nephrolithiasis	0.000158	0.000385	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000151	0.000367	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000148	0.00036	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000148	0.00036	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000134	0.000327	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000124	0.000303	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000123	0.0003	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000114	0.000278	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000114	0.000278	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000112	0.000274	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000111	0.000272	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SPP1—nephrolithiasis	0.000111	0.00027	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—AQP1—nephrolithiasis	0.000105	0.000257	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SPP1—nephrolithiasis	9.77e-05	0.000238	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CHRM3—nephrolithiasis	9.53e-05	0.000232	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	8.43e-05	0.000205	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—AQP1—nephrolithiasis	8.13e-05	0.000198	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CHRM3—nephrolithiasis	7.35e-05	0.000179	CbGpPWpGaD
